Blood cancer Clinical Trials in Aurora, CO
As of August 2026, 47 paid clinical trials are recruiting for Blood cancer in Aurora, Colorado. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Aurora
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
48 clinical trials for Blood cancer
·Clear filters·A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial)
CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
Top Research Study Locations in Aurora
Researchers run research studies in Aurora, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Children's Hospital Colorado | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Acute Myeloid Leukemia | 167 |
| University of Colorado Anschutz Medical Campus | Obesity, Cannabis Use Disorder, Parkinson Disease | 102 |
| University of Colorado | Parkinson Disease, Acute Myeloid Leukemia, Barrett Esophagus | 84 |
| University of Colorado Hospital | Acute Kidney Injury, Carcinoma, Non-Small-Cell Lung, Lung Cancer | 57 |
| UCHealth University of Colorado Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Muscle Invasive Bladder Urothelial Carcinoma | 52 |
| University of Colorado Cancer Center | Breast Cancer, Advanced Solid Tumor, Melanoma | 35 |
| Rocky Mountain Regional VA Medical Center, Aurora, CO | Heart Failure, Aging, Chronic Obstructive Pulmonary Disease | 34 |
| University of Colorado Denver | Depression, Anxiety, Diabetes, Retinopathy | 30 |
| University of Colorado Anschutz | Acanthamoeba Keratitis, Adiposity, Alcohol Use Disorder | 20 |
| Children's Hospital of Colorado | Cystic Fibrosis, Muscular Atrophy, Spinal, Abnormal Glucose Tolerance | 15 |
| Childrens Hospital Colorado | Hypochondroplasia, Adolescent Obesity, Anger | 15 |
| Rocky Mountain Regional VA Medical Center | Hypertension, Melanoma, Acute Lymphoblastic Leukemia | 14 |
| GSK Investigational Site | Asthma, Bronchiectasis, Gastrointestinal Neoplasms | 11 |
| University of Colorado - Anschutz Medical Campus | Aging, Hypertension, Interstitial Lung Disease | 11 |
| Rocky Mountain Cancer Centers-Aurora | Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm, Non-Hodgkin Lymphoma | 10 |
| Rocky Mountain Cancer Centers | Breast Cancer, Higher-risk Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | 9 |
| University of Colorado School of Medicine | Cervical Cancer, Choline Deficiency, Diffuse Large B Cell Lymphoma (DLBCL) | 7 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Advanced/Metastatic Urothelial Cancer, B-Cell Non-Hodgkins Lymphoma | 6 |
| University of Colorado, Denver | Arrhythmogenic Right Ventricular Cardiomyopathy, Arteriovenous Malformations, Cannabis Smoking | 5 |
| Barbara Davis Center | Type 1 Diabetes, Type 1 Diabetes (T1D), Diabetes Mellitus, Type 1 Diabetes | 5 |
| Colorado Children's Hospital | Anesthesia, Caregiver Stress, Children | 5 |
| University of Colorado Denver Anschutz Medical Campus | IUGR, Pregnancy, Frostbite | 5 |
| University of Colorado Hospital - Anschutz Cancer Pavilion | Advanced Liver Cancers, Advanced Melanoma, Advanced Or Metastatic Merkel Cell Carcinoma | 5 |
| University of Colorado, Anschutz Medical Campus | Advanced Melanoma, Amputation, Bone Anchored Devices | 5 |
| Barbara Davis Center for Diabetes | Type 1 Diabetes, Type 1 Diabetes (T1D), Type 1 Diabetes Mellitus | 4 |
Active & Upcoming Studies in Aurora (2026)
Recruiting trials in Aurora grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (285 active studies)
- Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment · University of Colorado, Denver
- Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma · Phase 2 · University of Colorado, Denver
Diabetes & metabolic (84 active studies)
- Digitally Enhanced Cognitive-Behavioral Therapy · Colorado State University
- Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans · VA Office of Research and Development
Cardiovascular (62 active studies)
- A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation · Phase 2 · Bayer
- Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD · VA Office of Research and Development
Neurology & pain (59 active studies)
- Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · VA Office of Research and Development
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
Pediatric (30 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- Asthma Ctrl SMART Trial · Children's Hospital Medical Center, Cincinnati
Mental health & behavior (20 active studies)
- Digitally Enhanced Cognitive-Behavioral Therapy · Colorado State University
- Multi-Site Trial of Tirzepatide for Smoking Cessation · Phase 2 · University of Southern California
HIV / STI (14 active studies)
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
Vaccines (7 active studies)
Eye & vision (5 active studies)
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
- A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) · Phase 1, Phase 2 · Splice Bio
Common conditions studied in Aurora
- Breast Cancer (19 active studies)
- Obesity (17 active studies)
- Heart Failure (15 active studies)
- Colorectal Cancer (12 active studies)
- Melanoma (11 active studies)
- Type 1 Diabetes (11 active studies)
Leading research sponsors in Aurora
- University of Colorado, Denver
- VA Office of Research and Development
- National Cancer Institute (NCI)
- Children's Oncology Group
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Aurora?
There are approximately 1,048 recruiting clinical trials in Aurora, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Aurora pay participants?
Most recruiting trials in Aurora compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Aurora?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Aurora?
The most common conditions under active study in Aurora include Breast Cancer (19), Obesity (17), Heart Failure (15), Colorectal Cancer (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Aurora?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Aurora on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Aurora?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Aurora?
Recruiting research sites in Aurora include Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, University of Colorado, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Aurora right now?
The largest active categories in Aurora are Cancer & tumors (285), Diabetes & metabolic (84), Cardiovascular (62). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.